369 related articles for article (PubMed ID: 23644658)
21. Somatic mutations of the von Hippel-Lindau tumor suppressor gene and loss of heterozygosity on chromosome 3p in human glial tumors.
Kanno H; Shuin T; Kondo K; Yamamoto I; Ito S; Shinonaga M; Yoshida M; Yao M
Cancer Res; 1997 Mar; 57(6):1035-8. PubMed ID: 9067265
[TBL] [Abstract][Full Text] [Related]
22. Absence of p53 autoantibodies in sera from glioma patients.
Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W
Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045
[TBL] [Abstract][Full Text] [Related]
23. Gliomagenesis arising from Pten- and Ink4a/Arf-deficient neural progenitor cells is mediated by the p53-Fbxw7/Cdc4 pathway, which controls c-Myc.
Kim HS; Woolard K; Lai C; Bauer PO; Maric D; Song H; Li A; Kotliarova S; Zhang W; Fine HA
Cancer Res; 2012 Nov; 72(22):6065-75. PubMed ID: 22986743
[TBL] [Abstract][Full Text] [Related]
24. Expression of p53 and prognosis in children with malignant gliomas.
Pollack IF; Finkelstein SD; Woods J; Burnham J; Holmes EJ; Hamilton RL; Yates AJ; Boyett JM; Finlay JL; Sposto R;
N Engl J Med; 2002 Feb; 346(6):420-7. PubMed ID: 11832530
[TBL] [Abstract][Full Text] [Related]
25. Adenovirus-mediated transfer of p33ING1 with p53 drastically augments apoptosis in gliomas.
Shinoura N; Muramatsu Y; Nishimura M; Yoshida Y; Saito A; Yokoyama T; Furukawa T; Horii A; Hashimoto M; Asai A; Kirino T; Hamada H
Cancer Res; 1999 Nov; 59(21):5521-8. PubMed ID: 10554029
[TBL] [Abstract][Full Text] [Related]
26. The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood.
Pollack IF; Hamilton RL; Finkelstein SD; Campbell JW; Martinez AJ; Sherwin RN; Bozik ME; Gollin SM
Cancer Res; 1997 Jan; 57(2):304-9. PubMed ID: 9000573
[TBL] [Abstract][Full Text] [Related]
27. Reduced latency but no increased brain tumor penetrance in mice with astrocyte specific expression of a human p53 mutant.
Klein MA; Rüedi D; Nozaki M; Dell EW; Diserens AC; Seelentag W; Janzer RC; Aguzzi A; Hegi ME
Oncogene; 2000 Nov; 19(47):5329-37. PubMed ID: 11103934
[TBL] [Abstract][Full Text] [Related]
28. High linear energy transfer carbon radiation effectively kills cultured glioma cells with either mutant or wild-type p53.
Iwadate Y; Mizoe J; Osaka Y; Yamaura A; Tsujii H
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):803-8. PubMed ID: 11395250
[TBL] [Abstract][Full Text] [Related]
29. Increased levels of p21WAF1/Cip1 in human brain tumors.
Jung JM; Bruner JM; Ruan S; Langford LA; Kyritsis AP; Kobayashi T; Levin VA; Zhang W
Oncogene; 1995 Nov; 11(10):2021-8. PubMed ID: 7478521
[TBL] [Abstract][Full Text] [Related]
30. Discovery of a perinecrotic 60 kDa MDM2 isoform within glioma spheroids and glioblastoma biopsy material.
Bell HS; Whittle IR; Bader SA; Wharton SB
Neuropathol Appl Neurobiol; 2005 Apr; 31(2):191-202. PubMed ID: 15771712
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.
Watanabe K; Tachibana O; Sata K; Yonekawa Y; Kleihues P; Ohgaki H
Brain Pathol; 1996 Jul; 6(3):217-23; discussion 23-4. PubMed ID: 8864278
[TBL] [Abstract][Full Text] [Related]
32. O6-methylguanine DNA methyltransferase gene promoter methylation status in gliomas and its correlation with other molecular alterations: first Indian report with review of challenges for use in customized treatment.
Jha P; Suri V; Jain A; Sharma MC; Pathak P; Jha P; Srivastava A; Suri A; Gupta D; Chosdol K; Chattopadhyay P; Sarkar C
Neurosurgery; 2010 Dec; 67(6):1681-91. PubMed ID: 21107199
[TBL] [Abstract][Full Text] [Related]
33. Introduction of wild-type p53 enhances thrombospondin-1 expression in human glioma cells.
Harada H; Nakagawa K; Saito M; Kohno S; Nagato S; Furukawa K; Kumon Y; Hamada K; Ohnishi T
Cancer Lett; 2003 Feb; 191(1):109-19. PubMed ID: 12609716
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease.
da Costa CA; Sunyach C; Giaime E; West A; Corti O; Brice A; Safe S; Abou-Sleiman PM; Wood NW; Takahashi H; Goldberg MS; Shen J; Checler F
Nat Cell Biol; 2009 Nov; 11(11):1370-5. PubMed ID: 19801972
[TBL] [Abstract][Full Text] [Related]
35. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
[TBL] [Abstract][Full Text] [Related]
36. Homozygous p53 gene mutation in a radiation-induced glioblastoma 10 years after treatment for an intracranial germ cell tumor: case report.
Tada M; Sawamura Y; Abe H; Iggo R
Neurosurgery; 1997 Feb; 40(2):393-6. PubMed ID: 9007876
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of bax in human glioma cell lines.
Vogelbaum MA; Tong JX; Perugu R; Gutmann DH; Rich KM
J Neurosurg; 1999 Sep; 91(3):483-9. PubMed ID: 10470825
[TBL] [Abstract][Full Text] [Related]
38. Negative regulation of p53 by the long isoform of ErbB3 binding protein Ebp1 in brain tumors.
Kim CK; Nguyen TL; Joo KM; Nam DH; Park J; Lee KH; Cho SW; Ahn JY
Cancer Res; 2010 Dec; 70(23):9730-41. PubMed ID: 21098709
[TBL] [Abstract][Full Text] [Related]
39. [Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].
Huang L; Jiang T; Yuan F; Li GL; Xu LX; Cui Y
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):752-8. PubMed ID: 22335907
[TBL] [Abstract][Full Text] [Related]
40. Functional evaluation of p53 and PTEN gene mutations in gliomas.
Kato H; Kato S; Kumabe T; Sonoda Y; Yoshimoto T; Kato S; Han SY; Suzuki T; Shibata H; Kanamaru R; Ishioka C
Clin Cancer Res; 2000 Oct; 6(10):3937-43. PubMed ID: 11051241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
